A frequent complication in liver cirrhosis is malnutrition, which is associated with the
progression of liver failure, and with a higher rate of complications including infections …

The current epidemic of non-alcoholic fatty liver disease (NAFLD) is reshaping the field of
hepatology all around the world. The widespread diffusion of metabolic risk factors such as …

This update of evidence-based guidelines (GL) aims to translate current evidence and
expert opinion into recommendations for multidisciplinary teams responsible for the optimal …

This guidance provides a data‐supported approach to the diagnostic, therapeutic, and
preventive aspects of nonalcoholic fatty liver disease (NAFLD) care. A “Guidance” document …

Nonalcoholic fatty liver disease (NAFLD) affects 25% of the global adult population with a
range of 13.5% in Africa and 31.8% in the Middle East. Nonalcoholic fatty liver disease is …

Because of global epidemics of obesity and type 2 diabetes, the prevalence of non-alcoholic
fatty liver disease (NAFLD) is increasing both in Europe and the United States, becoming …

Liver disease is the twelfth commonest cause of mortality in adults in the United States,
resulting in 34,000 deaths annually from cirrhosis. 7 In addition, the rising incidence of HCC …

This practice guideline has been approved by the American Association for the Study of
Liver Diseases and the American Society of Transplantation. These recommendations …

Objective: To evaluate the prevalence of sarcopenia among European patients with
resectable hepatocellular carcinoma (HCC) and to assess its prognostic impact on overall …

Intended for use by physicians, these recommendations suggest preferred approaches to
the diagnostic, therapeutic, and preventive aspects of care. They are intended to be flexible …